Nanophosphors-Based White Light Sources.

Nanomaterials (Basel)

Department of Physics, Boston College, Chestnut Hill, MA 02215, USA.

Published: July 2019

Miniaturization requests and progress in nanofabrication are prompting worldwide interest in nanophosphors as white-emission mercury-free lighting sources. By comparison with their bulk counterparts, nanophosphors exhibit reduced concentration quenching effects and a great potential to enhance luminescence efficiency and tunability. In this paper, the physics of the nanophoshors is overviewed with a focus on the impact of spatial confinement and surface-to-volume ratio on the luminescence issue, as well as rare earth-activated multicolor emission for white light (WL) output. In this respect, the prominently practiced strategies to achieve WL emission are single nanophosphors directly yielding WL by means of co-doping and superposition of the individual red, green, and blue emissions from different nanophosphors. Recently, a new class of efficient broadband WL emitting nanophosphors has been proposed, i.e., nominally un-doped rare earth free oxide (yttrium oxide, YO) nanopowders and Cr transition metal-doped garnet nanocrystals. In regard to this unconventional WL emission, the main points are: it is strictly a nanoscale phenomenon, the presence of an emitting center may favor WL emission without being necessary for observing it, and, its inherent origin is still unknown. A comparison between such an unconventional WL emission and the existing literature is presented to point out its novelty and superior lighting performances.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6669494PMC
http://dx.doi.org/10.3390/nano9071048DOI Listing

Publication Analysis

Top Keywords

white light
8
unconventional emission
8
nanophosphors
5
emission
5
nanophosphors-based white
4
light sources
4
sources miniaturization
4
miniaturization requests
4
requests progress
4
progress nanofabrication
4

Similar Publications

Background: Urinary formic acid (FA) has been reported to be a biomarker for Alzheimer's disease (AD). However, the association between FA and pathological changes in memory clinic patients is currently unclear.

Objective: This study aims to investigate associations between FA and pathological changes across different cognitive statuses in memory clinic patients.

View Article and Find Full Text PDF

Divergent roles of mA in orchestrating brown and white adipocyte transcriptomes and systemic metabolism.

Nat Commun

January 2025

Section of Islet Cell and Regenerative Biology, Joslin Diabetes Center; Department of Medicine, BIDMC; Harvard Stem Cell Institute, Harvard Medical School, Boston, MA, USA.

N-methyladenosine (mA) is among the most abundant mRNA modifications, yet its cell-type-specific regulatory roles remain unclear. Here we show that mA methyltransferase-like 14 (METTL14) differentially regulates transcriptome in brown versus white adipose tissue (BAT and WAT), leading to divergent metabolic outcomes. In humans and mice with insulin resistance, METTL14 expression differs significantly from BAT and WAT in the context of its correlation with insulin sensitivity.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Mayo Clinic, Jacksonville, FL, USA.

Background: The immune system is substantially involved in the development and progression of age-related cognitive decline and Alzheimer's disease (AD).

Method: As genetic and environmental factors interactively impact these conditions, we investigated how risk factors such as APOE genotype, age, and sex influence immune activation markers and AD biomarkers in cerebrospinal fluid (CSF) in elderly individuals enrolled in the Mayo Clinic Study of Aging cohort. Among cognitively unimpaired individuals aged over 65 at the baseline visit (N=298), we measured 365 CSF immune activation markers using the proximity extension assay.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Glenn Biggs Institute for Alzheimer's & Neurodegenerative Diseases, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.

Background: The MarkVCID consortium was established to address the paucity of biomarkers for vascular contributions to cognitive impairment and dementia (VCID), a leading cause of dementia. Plasma neurofilament light (NfL), a neuroaxonal injury marker elevated in several neurological and neurodegenerative diseases, was selected as one of the first biomarkers to be examined. We performed comprehensive instrumental and clinical validation of the Quanterix Simoa NfL assay using the first MarkVCID cohort.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Washington University in St. Louis, School of Medicine, St. Louis, MO, USA.

Background: Autosomal dominant Alzheimer disease (ADAD) is characterized by genetic mutations affecting the beta-amyloid (Aβ) pathway. However, vascular and immune factors play important roles which are not completely understood. Understanding the function of the neurovascular unit (NVU) comprised of neurons, glial cells, and vasculature, at different disease stages appears ideal to developing and evaluating therapeutics.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!